This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Borgwarner Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: CARBAPENEM COMPOUNDS
Introduction
Michael Wayne Miller is an inventor based in the United States. He has contributed to the field of pharmaceuticals, particularly in the development of carbapenem compounds. These compounds are significant for their potential use in treating bacterial infections, especially those that are drug-resistant.
Latest Patents
Miller's notable patent is titled "Carbapenem Compounds," with the international application number PCT/IN2017/000060. This patent was published under the Patent Cooperation Treaty (PCT) on September 21, 2017. The invention relates to carbapenem compounds, their stereoisomers, and pharmaceutically acceptable salts or N-oxides, which may be useful in treating bacterial infections.
Career Highlights
Despite having no patents attributed to him, Miller's work on carbapenem compounds showcases his involvement in innovative pharmaceutical research. His contributions are aimed at addressing critical health challenges posed by drug-resistant bacteria.
Collaborations
Miller has collaborated with several notable individuals in the pharmaceutical field, including Gopalan Balasubramanian and Maneesh Paul-Satyaseela. These collaborations have been essential in advancing the research and development of carbapenem compounds.
Conclusion
Michael Wayne Miller's work in the field of carbapenem compounds highlights his commitment to addressing significant medical challenges. His contributions, although limited in patent numbers, reflect the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile